EmbectaEMBC
Market Cap: $911M
About: Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.
Employees: 2,200
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
138% more call options, than puts
Call options by funds: $2.75M | Put options by funds: $1.15M
0.01% more ownership
Funds ownership: 96.9% [Q1] → 96.91% (+0.01%) [Q2]
3% less funds holding
Funds holding: 360 [Q1] → 350 (-10) [Q2]
6% less capital invested
Capital invested by funds: $741M [Q1] → $697M (-$44M) [Q2]
12% less repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 103
17% less first-time investments, than exits
New positions opened: 48 | Existing positions closed: 58
100% less funds holding in top 10
Funds holding in top 10: 1 [Q1] → 0 (-1) [Q2]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Morgan Stanley Cecilia Furlong 38% 1-year accuracy 3 / 8 met price target | 24%downside $12 | Underweight Maintained | 15 Jul 2024 |
Financial journalist opinion
Based on 3 articles about EMBC published over the past 30 days